Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. (Q53151022)
Jump to navigation
Jump to search
scientific article published on 24 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. |
scientific article published on 24 June 2011 |
Statements
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study. (English)
1 reference
Birgit Högl
1 reference
Luigi Ferini-Strambi
1 reference
Werner Poewe
1 reference
Claudia Trenkwalder
1 reference
Wolfgang Oertel
1 reference
Karin Stiasny-Kolster
1 reference
Heike Beneš
1 reference
Andreas Fichtner
1 reference
Erwin Schollmayer
1 reference
Ralf Kohnen
1 reference
Diego García-Borreguero
1 reference
SP710 study group
1 reference
24 June 2011
1 reference
10
1 reference
8
1 reference
710-720
1 reference
Identifiers
1 reference